KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Gains from Sales and Divestitures: 2009-2015

Historic Gains from Sales and Divestitures for Emergent BioSolutions (EBS) over the last 7 years, with Dec 2015 value amounting to $422,515.

  • Emergent BioSolutions' Gains from Sales and Divestitures was N/A to $413,752 in Q3 2017 from the same period last year, while for Sep 2017 it was $413,752, marking a year-over-year change of. This contributed to the annual value of $422,515 for FY2015, which is 17.04% up from last year.
  • Per Emergent BioSolutions' latest filing, its Gains from Sales and Divestitures stood at $422,515 for FY2015, which was up 17.04% from $361,010 recorded in FY2014.
  • In the past 5 years, Emergent BioSolutions' Gains from Sales and Divestitures registered a high of $422,515 during FY2015, and its lowest value of -$392,000 during FY2011.
  • Its 3-year average for Gains from Sales and Divestitures is $373,674, with a median of $361,010 in 2014.
  • In the last 5 years, Emergent BioSolutions' Gains from Sales and Divestitures tumbled by 1,131.58% in 2011 and then surged by 166.51% in 2012.
  • Over the past 5 years, Emergent BioSolutions' Gains from Sales and Divestitures (Yearly) stood at -$392,000 in 2011, then surged by 166.51% to $260,738 in 2012, then climbed by 29.44% to $337,498 in 2013, then climbed by 6.97% to $361,010 in 2014, then grew by 17.04% to $422,515 in 2015.